Shifeng Mao
AHN Cancer Institute-Med Onc & Infusions at Allegheny General Hospital
Office
(412) 325-5700
Fax (412) 442-2570 314 East North Avenue, Pittsburgh, PA 15212Call today!
About
Shifeng Mao
Shifeng S Mao, MD, PhD, is the chair of the AHN Cancer Institute urological oncology team. His practice and research focus on genitourinary cancers, including prostate cancer, bladder cancer, kidney cancer, and testicular cancer. He is an Associate Professor Medicine at Drexel University College of Medicine. Dr. Mao is an active researcher and the principal investigator of many clinical trials. He has active collaborations with colleagues from Johns Hopkins Kimmel Cancer Center and Carnegie Mellon University. He is the recipient of American Society of Clinical Oncology (ASCO) Young Investigator Award. He has published many research studies in medical journals and presented his findings at national conferences. His experience in cancer research gives him a unique perspective and insight into the biology of cancer, which enhances his clinical care with patients. Dr. Mao earned his medical degree from Beijing Medical University and his doctorate in medical pathology from University of Tennessee Health Science Center. He completed his residency at New York University School of Medicine and continued his studies through a fellowship at the University of Texas Medical School at Houston/MD Anderson Cancer Center.
Primary Specialty
Hematologist
Practice
AHN Cancer Institute-Med Onc & Infusions at Allegheny General Hospital
Gender
Male
Education
Beijing Medical University
Training
New York University School of Medicine Internship Residencies, University of Texas MD Anderson Cancer Center
Certification
American Board of Internal Medicine-Hematology, American Board of Internal Medicine-Medical Oncology
Accepting New Patients
Degrees
Medical Doctor
Admitting Hospitals
Allegheny General Hospital, Allegheny Valley Hospital, West Penn Hospital, Jefferson Hospital, Forbes Hospital
Office Name
AHN Cancer Institute-Med Onc & Infusions at Allegheny General Hospital
Languages
Chinese - Mandarin, English
Business Hours
Monday:10:00 AM - 4:00 PM
Tuesday:10:00 AM - 4:00 PM
Wednesday:10:00 AM - 4:00 PM
Thursday:10:00 AM - 4:00 PM
Friday:10:00 AM - 4:00 PM
Saturday:Closed
Sunday:Closed
Services
clear cell renal cancer, chemotherapy iv infusion, multi-cancer early detection blood test, relapsed myeloma, testicular tumor, adjuvant chemotherapy, solid tumors, advanced malignancies, systemic therapy, mediastinal lymphadenopathy, gleason score, intravesical chemotherapy, hereditary kidney cancer, hormone receptor negative breast cancer, colorectal metastases, ductal carcinoma in situ (dcis), lobular carcinoma in situ (lcis), personal history of cancer, intestinal cancer, secondary cancer screening, long term side effects of cancer treatment, personal history of radiation therapy, personal history of chemotherapy, blood cancer chemotherapy, hyperthermic intraperitoneal chemotherapy (hipec), gynecologic cancer, blood transfusion therapy, prostate cancer chemotherapy, bladder cancer chemotherapy, testicular cancer chemotherapy, non steroidal aromatase inhibitors, hormone based chemotherapy, adolescent and young adult cancer (aya), metastatic rib cancer, breast cancer immunotherapy, relapsed hodgkin lymphoma, lymphoproliferative disorder, intravesical therapy, hormone receptor positive breast cancer, her2 positive breast cancer, carcinoma of unknown primary, targeted molecular therapy, cancer related anxiety disorder, cancer related depression, cancer related bereavement disorder, cancer related stress disorder, intrathecal chemotherapy, maintenance chemotherapy, consolidation chemotherapy, induction chemotherapy, er negative breast cancer, urachal tumor, malignant brain neoplasm, clinical trials, squamous cell carcinoma of the head and neck, aids related malignancies, intraarterial chemotherapy of tumors, cervical and endometrial cancers, genitourinary cancers, inflammatory breast cancer, recurrent breast cancer, occupational cancer, brain metastases, ear and temporal bone cancer, liver metastases, malignant carcinoid tumor of colon, ear canal cancer, hodgkin lymphoma, triple negative breast cancer, breast cancer therapy, breast cancer counseling, cancer immunotherapy, prostate cancer, adenocarcinoma of lung, acute lymphoblastic leukemia (all), abdominal chemotherapy, abdominal cancer, breast cancer, papillary cancer of thyroid, medullary cancer of thyroid, follicular cancer of thyroid, parotid cancer, squamous cancer of the lung, esophageal cancer, tracheal cancer, oral complications of cancer, non hodgkin lymphoma, myeloproliferative diseases, lymphedema therapy, hematologic malignancies, head and neck cancer, cancer related fatigue, hereditary cancer risk, ovarian cancer, head and neck tumors, reduced intensity conditioning regimens, bladder cancer, thyroid cancer, stomach cancer
Additional Services
Oncologist
Consumer Feedback
Add a Review
There are no recent reviews. Be the first!